Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,246
Total Claims
$701K
Drug Cost
564
Beneficiaries
$1,244
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-94%
Opioid rate vs peers
0.1% vs 2.5% avg
+10%
Cost per patient vs peers
$1,244 vs $1,128 avg
+29%
Brand preference vs peers
10.9% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
19
Opioid Claims
$73
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,424 claims · $507K
Generic: 11,665 claims · $191K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 69 | $78K |
| Insulin Nph Hum/Reg Insulin Hm | 149 | $54K |
| Rivaroxaban | 59 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 131 | $53K |
| Linagliptin/Metformin Hcl | 29 | $37K |
| Apixaban | 37 | $26K |
| Sitagliptin Phos/Metformin Hcl | 17 | $26K |
| Insulin Lispro | 51 | $25K |
| Empagliflozin | 19 | $23K |
| Levothyroxine Sodium | 305 | $18K |
| Ticagrelor | 15 | $15K |
| Candesartan/Hydrochlorothiazid | 55 | $14K |
| Budesonide/Formoterol Fumarate | 30 | $12K |
| Sitagliptin Phosphate | 11 | $11K |
| Candesartan Cilexetil | 57 | $11K |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
2.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About